| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846676 In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 01/20/2005 | WO2003099762A8 Agents and methods for the treatment of disorders associated with oxidative stress |
| 01/20/2005 | US20050014827 Formulations containing polyphenol derivatives; food and feed supplements; bactericidal, fungicidal and virucidal effects |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
| 01/20/2005 | US20050014696 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050013873 Use of glass compositions for achieving an antioxidative effect |
| 01/19/2005 | EP1498395A1 Use of a glass composition with the aim of attaining an antioxidative effect |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1496920A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation |
| 01/19/2005 | EP1496742A1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 01/19/2005 | EP1301515B1 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | CN1568182A Compositions for lessening oxidative stress |
| 01/19/2005 | CN1566126A Novel natural drug effective region |
| 01/19/2005 | CN1565610A Chinese herbal medicine compositions and is usage |
| 01/19/2005 | CN1565474A Biochemical nucleic acid fulvic acid oral liquid production method |
| 01/19/2005 | CN1565471A Breviscapine drop pill |
| 01/19/2005 | CN1565451A Naloxone Hydrochloride nose powder preparation |
| 01/19/2005 | CN1565450A Naloxone Hydrochloride Injection and its preparation method |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/18/2005 | US6844456 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
| 01/13/2005 | WO2004075907A3 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/12/2005 | EP1496059A1 Fused bicyclic pyrimidine derivatives |
| 01/12/2005 | EP1494677A1 Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1562375A Combination of medication produced from attenuated salmonella bacteria possessing effect of radiation protection and anti tumour |
| 01/12/2005 | CN1562346A Compound preparation of cyclicamp or its ramification and counteractant for free radical |
| 01/12/2005 | CN1562345A Drug combination including activator for metabolism of brain and free radical scavenger |
| 01/12/2005 | CN1562207A Detoxicant |
| 01/12/2005 | CN1183938C Chinese medicine prepn for expelling toxin and resisting cancer and its preparing method and use |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841545 Heat resistance; anticancer drug |
| 01/11/2005 | US6841180 Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| 01/11/2005 | CA2215351C Process for isolating galanthamine |
| 01/06/2005 | WO2005000335A2 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004128 4-(6-chloro-, methyl- or thien-3-yl-oxazolo[4,5-b]pyrid-2-yl)-1,4-diazabicyclo[3.2.2]nonane or salts; nicotinic receptor associated disorders; cholinergic agents |
| 01/06/2005 | US20050002961 Concentrate comprising green tea, grape skin extract and grape extract, the production thereof and use of the same |
| 01/06/2005 | CA2528347A1 Orally bioavailable low molecular weight metalloporphyrins as antioxidants |
| 01/06/2005 | CA2527957A1 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492524A1 Vitamin combination for providing protection during the chemotherapy and/or radiotherapy of malignant tumours |
| 01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
| 01/05/2005 | EP1411909B1 Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 01/05/2005 | EP1282414B1 Felbamate derived compounds for treating neuropathic pain |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | CN1561214A New formulations and use thereof |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1559647A Preparation method of seaweed antioxidation active component |
| 01/05/2005 | CN1559583A Applicaton of medicine for garlic oil anti radiation indnced aleucocytosis and DNA injury |
| 01/05/2005 | CN1559539A Medicinal mixture possessing alpha glycocidase inhibiting activity and its use |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1559386A Method for preparing emodin liquid |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/04/2005 | US6838469 Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activity |
| 01/04/2005 | CA2102072C Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence |
| 12/30/2004 | US20040266844 Antimicrobial and radioprotective compounds |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266825 Using impurity as marker for stability of paroxetine hydrochloride; quantitative analysis |
| 12/30/2004 | US20040265231 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
| 12/29/2004 | WO2004113319A1 Novel chromene compound |
| 12/29/2004 | WO2004113318A1 Flavanone compound and uses thereof |
| 12/29/2004 | WO2004112816A1 Fermentation product and process for producing the same |
| 12/29/2004 | EP1491201A1 Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides |
| 12/29/2004 | EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490078A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450 |
| 12/29/2004 | EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 12/29/2004 | EP1490050A2 Methods for alzheimer's disease treatment and cognitive enhancement |
| 12/29/2004 | EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 12/29/2004 | EP1124576B1 Method for preparing solid phase conjugate vaccines |
| 12/29/2004 | CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/29/2004 | CN1558772A Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 12/29/2004 | CN1557419A Chinese medicine medlar-Chinese date preparation for promoting lead expel in high blood lead concentration children and its preparing process |
| 12/29/2004 | CN1557417A Purslane extract and its anoxia resistant usage |
| 12/29/2004 | CN1557388A Poisonous element content decreasing Kawa extracts and its composition and preparing method |
| 12/29/2004 | CN1557370A Antihyperglycemic and oxidation resistant health products and preparing process thereof |
| 12/29/2004 | CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 12/29/2004 | CN1181856C Medicine with functions of postponing senility and loosening the bowel to relieve constipation |
| 12/28/2004 | US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis |
| 12/28/2004 | US6835711 Use of poly-Glu,Tyr for neuroprotective therapy |
| 12/28/2004 | US6835401 Method of treating diseases caused by over-production of free-radicals |
| 12/28/2004 | US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery |
| 12/23/2004 | WO2004089354A3 Peptides and derivatives thereof as inhibitors of oxidative-induced degradation phenomena and compositions containing them |
| 12/23/2004 | WO2004084876A3 Use of compounds for the prevention of drug-induced cell toxicity |
| 12/23/2004 | US20040259927 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure |
| 12/23/2004 | US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |